@article{Simpson_Yap_2021,
title={Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis},
volume={97},
ISSN={1526-632X},
url={http://dx.doi.org/10.1212/wnl.0000000000012753},
DOI={10.1212/wnl.0000000000012753},
number={19},
journal={Neurology},
publisher={Ovid Technologies (Wolters Kluwer Health)},
author={Simpson-Yap,
Steve and De Brouwer,
Edward and Kalincik,
Tomas and Rijke,
Nick and Hillert,
Jan A. and Walton,
Clare and Edan,
Gilles and Moreau,
Yves and Spelman,
Tim and Geys,
Lotte and Parciak,
Tina and Gautrais,
Clement and Lazovski,
Nikola and Pirmani,
Ashkan and Ardeshirdavanai,
Amin and Forsberg,
Lars and Glaser,
Anna and McBurney,
Robert and Schmidt,
Hollie and Bergmann,
Arnfin B. and Braune,
Stefan and Stahmann,
Alexander and Middleton,
Rodden and Salter,
Amber and Fox,
Robert J. and van der Walt,
Anneke and Butzkueven,
Helmut and Alroughani,
Raed and Ozakbas,
Serkan and Rojas,
Juan I. and van der Mei,
Ingrid and Nag,
Nupur and Ivanov,
Rumen and Sciascia do Olival,
Guilherme and Dias,
Alice Estavo and Magyari,
Melinda and Brum,
Doralina and Mendes,
Maria Fernanda and Alonso,
Ricardo N. and Nicholas,
Richard S. and Bauer,
Johana and Chertcoff,
Aníbal Sebastián and Zabalza,
Anna and Arrambide,
Georgina and Fidao,
Alexander and Comi,
Giancarlo and Peeters,
Liesbet},
year={2021},
month=nov }